• The secondary patent particularly irked some advocates because the drug’s development was largely underwritten by public funds, according to a 2020 analysis. That study found public sector funds contributed $455 million to $747 million to getting bedaquiline to market, compared to $90 million to $240 million from J&J.

      We pay for the development of the drug, they get the patent, then we pay for the drug. Socialize cost, privatize profits.

      • most of the hype about danger from talcum powder is quite fake. the link between cancer and the powder is hugely tenuous and the researchers are quite shameful. Poor J&J are being victimised when there are millions sufferring from the absence of their valuable and safe talcum powder,